Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10833631 | Molecular Genetics and Metabolism | 2014 | 8 Pages |
Abstract
Cardiovascular risk factor modification and targeted use of ERT reduce the risk of adverse outcomes related to Fabry disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
S.M. Sirrs, D.G. Bichet, R. Casey, J.T.R. Clarke, K. Lemoine, S. Doucette, M.L. West, On behalf of the CFDI investigators On behalf of the CFDI investigators,